本文選題：醫(yī)藥行業(yè) + 市場(chǎng)定位　； 參考：《北京交通大學(xué)》2017年碩士論文

【摘要】：2016年國家出臺(tái)了許多關(guān)于醫(yī)療、藥品、醫(yī)療器材方面的政策,正是在政府對(duì)醫(yī)藥行業(yè)監(jiān)管越來越嚴(yán)格的宏觀環(huán)境下,醫(yī)藥行業(yè)面臨要不斷提升產(chǎn)品質(zhì)量、降低產(chǎn)品價(jià)格、加強(qiáng)企業(yè)管理需求等挑戰(zhàn)。這些挑戰(zhàn)甚至?xí)䦃嚎s企業(yè)利潤(rùn)。如何在現(xiàn)有的經(jīng)營(yíng)環(huán)境下選擇合適的營(yíng)銷策略,提高企業(yè)利潤(rùn),成為我國醫(yī)藥企業(yè)當(dāng)前亟需解決的關(guān)鍵問題。本文以G公司為例,首先闡述研究背景及意義,研究方法、內(nèi)容及技術(shù)路線;其次梳理市場(chǎng)營(yíng)銷理論;通過調(diào)查G公司基本情況,產(chǎn)品、價(jià)格、渠道和促銷的營(yíng)銷現(xiàn)狀,發(fā)現(xiàn)其存在自產(chǎn)產(chǎn)品營(yíng)銷力度不足,外購價(jià)格策略單一,營(yíng)銷部門獨(dú)立導(dǎo)致資源分配不平衡,電商平臺(tái)促銷不足且線下促銷方式簡(jiǎn)單等問題;借助PSET等方法分析了企業(yè)的宏觀環(huán)境、行業(yè)環(huán)境,通過SWOT分析明確了企業(yè)面臨的市場(chǎng)機(jī)會(huì)、威脅及企業(yè)自身的優(yōu)勢(shì)、劣勢(shì),根據(jù)G公司的情況,選擇適合的營(yíng)銷戰(zhàn)略,利用STP理論,細(xì)分市場(chǎng)、選擇目標(biāo)市場(chǎng)并進(jìn)行市場(chǎng)定位,即制定營(yíng)銷戰(zhàn)術(shù):打造高端產(chǎn)品及服務(wù),整合產(chǎn)業(yè)鏈。最后運(yùn)用4P營(yíng)銷理論給出相應(yīng)的策略:加強(qiáng)產(chǎn)品開發(fā)及實(shí)現(xiàn)產(chǎn)品差異化;對(duì)產(chǎn)品實(shí)行分類定價(jià);定價(jià)增強(qiáng)分銷渠道的能力;強(qiáng)化多樣化的促銷方式。公司營(yíng)銷策略和策略有效的實(shí)施,需要公司組織、人才、資金和技術(shù)的支持。通過對(duì)G公司的營(yíng)銷策略研究,能夠進(jìn)一步抵御因?yàn)樗幤方?jīng)營(yíng)管理監(jiān)督加強(qiáng)帶來的諸多威脅,有利于企業(yè)提高其營(yíng)銷能力和公司業(yè)績(jī),同時(shí)具有較強(qiáng)的實(shí)踐價(jià)值和可操作性,對(duì)其他的醫(yī)藥企業(yè)的營(yíng)銷策略也具有一定的借鑒作用。
[Abstract]:In 2016, the state issued many policies on medical treatment, medicine, and medical equipment. It is precisely under the macro environment that the government is increasingly strict in regulating the pharmaceutical industry that the pharmaceutical industry is faced with the need to continuously improve product quality and reduce product prices. Strengthen business management needs and other challenges. These challenges can even reduce corporate profits. How to choose the appropriate marketing strategy and improve the profit under the existing operating environment has become the key problem that needs to be solved urgently in the pharmaceutical enterprises of our country at present. This article takes G Company as an example, first of all describes the research background and significance, research method, content and technical route; secondly, combs the marketing theory; through the investigation G company basic situation, the product, the price, the channel and the promotion marketing present situation, It is found that there are some problems such as insufficient marketing intensity of self-made products, single price strategy for outsourcing, unbalanced distribution of resources caused by the independence of marketing department, insufficient promotion of e-commerce platform and simple way of offline promotion. With the help of PSET and other methods, this paper analyzes the macro environment and industry environment of the enterprise. Through the analysis of SWOT, it makes clear the market opportunities, threats and the advantages and disadvantages of the enterprise itself. According to the situation of company G, it chooses the appropriate marketing strategy. Using STP theory, subdividing the market, selecting the target market and positioning the market, that is, to establish marketing tactics: to create high-end products and services, and to integrate the industrial chain. Finally, the corresponding strategies are given by using 4P marketing theory: strengthening product development and realizing product differentiation; implementing classified pricing of products; pricing enhancing the ability of distribution channels; strengthening diversified promotion methods. Effective implementation of marketing strategies and strategies requires organizational, talent, financial and technical support from the company. Through the research of G company's marketing strategy, it can further resist the many threats brought by the strengthening of drug management and management supervision, which is beneficial to the enterprise to improve its marketing ability and company performance, at the same time, it has strong practical value and maneuverability. The marketing strategy of other pharmaceutical enterprises also has a certain reference role.
【學(xué)位授予單位】：北京交通大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：F274;F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 孔慶林;費(fèi)蕓;;三精制藥死亡揭秘:營(yíng)銷PK研發(fā)[J];會(huì)計(jì)之友;2015年22期

2 陳曉健;;基于顧客感知價(jià)值的天福集團(tuán)營(yíng)銷策略分析[J];中國商論;2015年26期

3 徐真;;基于微信平臺(tái)的圖書營(yíng)銷策略探析[J];現(xiàn)代營(yíng)銷(下旬刊);2015年06期

4 周宇東;;華為公司的營(yíng)銷策略和跨國戰(zhàn)略[J];現(xiàn)代營(yíng)銷(下旬刊);2015年06期

5 張遠(yuǎn)燈;;論營(yíng)銷的消費(fèi)心理策略[J];現(xiàn)代營(yíng)銷(下旬刊);2015年06期

6 王穎;;微信“朋友圈”營(yíng)銷的SWOT分析及策略研究[J];現(xiàn)代營(yíng)銷(下旬刊);2015年03期

7 蔡旭;;我國醫(yī)藥第三終端市場(chǎng)現(xiàn)狀及對(duì)策研究[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2013年06期

8 葉忠康;遲桂華;;我國醫(yī)藥營(yíng)銷渠道模式現(xiàn)狀分析及改進(jìn)對(duì)策[J];物流科技;2012年06期

9 劉燕;;渠道變革風(fēng)險(xiǎn)的影響因素實(shí)證研究[J];當(dāng)代經(jīng)濟(jì);2012年02期

10 鄧明;;基于第三終端市場(chǎng)營(yíng)銷的藥品零售問題的研究[J];中國商貿(mào);2012年02期

相關(guān)碩士學(xué)位論文 前10條

1 呂靜楠;華潤(rùn)山東醫(yī)藥有限公司營(yíng)銷策略研究[D];山東大學(xué);2015年

2 楊淑寧;SH制藥公司藥品營(yíng)銷策略研究[D];長(zhǎng)安大學(xué);2015年

3 丁丁;B醫(yī)藥企業(yè)的營(yíng)銷策略研究[D];安徽大學(xué);2014年

4 周偉;S制藥公司營(yíng)銷渠道管理策略研究[D];華東理工大學(xué);2014年

5 楊春林;萊美藥業(yè)AS膠囊廣東市場(chǎng)營(yíng)銷策略研究[D];西南財(cái)經(jīng)大學(xué);2014年

6 許仁裕;BJFK醫(yī)藥公司市場(chǎng)營(yíng)銷策略研究[D];南京理工大學(xué);2013年

7 孟言;醫(yī)藥產(chǎn)品營(yíng)銷策略研究[D];寧波大學(xué);2013年

8 柳巍;農(nóng)村醫(yī)療改革背景下的醫(yī)藥營(yíng)銷渠道研究[D];湖南農(nóng)業(yè)大學(xué);2012年

9 吳s，

本文編號(hào)：1979503